Lyell Immunopharma Long Term Deferred Assets (Quarterly) Trends

Lyell Immunopharma, Inc. (LYEL)

23.90 +0.14 (+0.59%) USD | NASDAQ | Jan 20, 16:00

24.02 +0.12 (+0.50%) Pre-Market: 20:00

View Long Term Deferred Assets (Quarterly) for LYEL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Insmed, Inc.	--
Nektar Therapeutics	--
GT Biopharma, Inc.	--
Ionis Pharmaceuticals, Inc.	--
Regeneron Pharmaceuticals, Inc.	Upgrade